The IDK anti-SARS-CoV-2 IgM ELISA is for the qualitative determination of human IgM antibodies against the SARS-CoV-2 virus in suspected COVID-19 cases.
Detects IgM antibodies against the SARS-CoV-2 virus
For investigation of COVID-19 infection prior to seroconversion
Easily automated
Includes positive, negative and cut-off controls
The IDK anti-SARS-CoV-2 IgM ELISA is for the qualitative determination of human IgM antibodies against the SARS-CoV-2 virus in suspected COVID-19 cases. Seroconversion occurs at different time points, but studies have shown that IgM antibodies against SARS-CoV-2 can be detected in the blood in the majority of patients around 7 days after the onset of symptoms.
